Q1 2023 13F Holders as of 3/31/2023
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
31.6M
-
Number of holders
-
196
-
Total 13F shares, excl. options
-
39M
-
Shares change
-
+3.07M
-
Total reported value, excl. options
-
$937M
-
Value change
-
+$74.1M
-
Put/Call ratio
-
1.63
-
Number of buys
-
111
-
Number of sells
-
-84
-
Price
-
$23.99
Significant Holders of COLLEGIUM PHARMACEUTICAL, INC - Common Stock, par value $0.001 per share (COLL) as of Q1 2023
224 filings reported holding COLL - COLLEGIUM PHARMACEUTICAL, INC - Common Stock, par value $0.001 per share as of Q1 2023.
COLLEGIUM PHARMACEUTICAL, INC - Common Stock, par value $0.001 per share (COLL) has 196 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 39M shares
.
Largest 10 shareholders include BlackRock Inc. (5.81M shares), Rubric Capital Management LP (3.27M shares), EVENTIDE ASSET MANAGEMENT, LLC (2.63M shares), VANGUARD GROUP INC (2.31M shares), PRINCIPAL FINANCIAL GROUP INC (1.55M shares), STATE STREET CORP (1.35M shares), JANUS HENDERSON GROUP PLC (1.28M shares), RENAISSANCE TECHNOLOGIES LLC (1.21M shares), Invesco Ltd. (1.14M shares), and Camber Capital Management LP (1.05M shares).
This table shows the top 196 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.